Thank you, Mr. Speaker, and I appreciate the question. Some of the things that we need to look at in order to advance both the relaxation of internal restrictions and the relaxation of the border include things such as vaccine uptake in the NWT and what the science says about how effective the vaccines are to stop the transmission of the virus. We know the vaccines are effective to stop severe illness, but we don't know whether, once you have the vaccine, you can still carry the virus with you. You could still be exposed, and then carry the virus with you to another location. We have a significant portion of the population under 18 who have not received any vaccines, and we don't have the science yet on which vaccines may be useful for them. We have been looking, of course, at the variants. The variant numbers are growing in some southern jurisdictions. I last heard that 40 percent of the new cases in Ontario are variant cases. There are new variants in addition to the ones from the UK, South Africa, and Brazil, so that's another consideration.
What the Chief Public Health Officer has said is that, once we know more about these variables and once we have as much vaccine uptake as we hope for, which is 75 percent of the adult population, we will then be in a position to move into phase 3, and she said yesterday that she thought that would happen at the end of April. Thank you.